Partnerships

Sustainable & safe future of Food Systems(Future Foods)

Sustainable & safe future of Food Systems(Future Foods)

Partnership website: https://www.futurefoodspartnership.eu/

The Future Foods partnership will coordinate, align, and leverage European and national R&I efforts to future-proof food systems for co-benefits and provide solutions to the Farm to Fork strategy. The objective of the partnership is to collectively develop and implement an EU-wide committed research and innovation partnership to accelerate the transition towards healthy diets that are safe and sustainably produced, and consumed in resilient EU and global food systems.

Contact

Commission services: Daniela Lueth

 

 

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

How to use partnerships?

  • orientation
    Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
  • networking
    Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
  • ecosystem analysis
    Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
  • steering the agenda
    Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Author Do you have an additional question? Or spotted a mistake? Don't hesitate to contact me!
Image of Pascal Verheye
Pascal Verheye

pascal.verheye@vlaio.be

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.